Quantcast

Latest Microbicides for sexually transmitted diseases Stories

2010-11-23 13:28:42

Successful trial provides proof of concept for oral use of antiretrovirals in preventing HIV infections in men who have sex with men CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention. Results of the National Institutes of Health (NIH) sponsored study were announced today in the New England Journal of Medicine. Daily use of the widely used antiretroviral combination pill was...

2010-11-23 07:01:00

JOHANNESBURG and WASHINGTON, Nov. 23, 2010 /PRNewswire-USNewswire/ -- The Global Campaign for Microbicides (GCM) welcomes today's news from the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Disease (NIAID) of the US National Institutes of Health (NIH) and the Gladstone Institutes of the University of California, San Francisco that daily use of oral emtricitabine (FTC) with tenofovir (TDF) in one tablet shows promise to safely and effectively help to prevent...

2010-09-03 12:14:00

NEW YORK, Sept. 3 /PRNewswire-USNewswire/ -- AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only...

2010-07-19 15:31:00

CAPRISA 004 trial shows moderate protection against transmission of virus JOHANNESBURG and WASHINGTON, July 19 /PRNewswire-USNewswire/ -- Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided...

2010-07-19 13:55:00

VIENNA, July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna. "We believe that the most responsible plan of action now is to quickly and efficiently...

2010-07-02 20:15:44

Researchers from Boston University School of Medicine (BUSM) have identified two molecules that when activated by drugs, can inhibit a number of specific aspects of HIV transmission. These findings, published July 1 in the open-access journal PLoS Pathogens, may lead to therapies that target mucosal HIV transmission. Worldwide, heterosexual transmission accounts for most new HIV infections, with a majority of these occurring in developing countries. Immune cells within the vaginal, cervical,...

2010-06-08 10:45:00

WASHINGTON, June 8 /PRNewswire/ -- The nonprofit International Partnership for Microbicides (IPM) today announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug (ARV) that could one day be used to prevent HIV transmission during sex. The clinical trial, known as IPM 015, tests the safety and acceptability of an innovative approach that adapts a successful technology from the reproductive health field to give women around the...

2010-01-26 12:00:00

BETHLEHEM, Pa., Jan. 26 /PRNewswire/ -- Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV. According to Robert Lee, VP Pharmaceutical Development at Particle Sciences, "Particle Sciences is well qualified for this challenge having extensive expertise in mucosal formulation and previous...

2009-12-14 01:25:00

Funding and Support for HIV Prevention Research Must Continue NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Microbicides Development Programme announced earlier today that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 microbicide reduces the risk of HIV infection. Reacting to today's announcement, AVAC executive director Mitchell Warren said, "Of course, we are disappointed to hear these...

5496995050be89495ef5f73b85bcf52b1
2009-07-10 09:35:00

Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more susceptible to HIV infection. The study appears today in the online version of the Journal of Infectious Diseases.Betsy C. Herold, M.D.For years, scientists have been trying to develop a topical vaginal microbicide for...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.